Clinical Trial Update: Probiotics in Mild Alzheimer's Disease [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 clinical trial evaluating a probiotic therapy for individuals with mild Alzheimer's disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Probiotic (probiotic)

Snippet

Sponsor: University of Nicosia | Conditions: Neurodegenerative Diseases, Cognition Disorders in Old Age | EARLY_Phase 1 | Status: RECRUITING